Tradr 2X Long XNDX is a small, single-stock leveraged exchange-traded fund listed on Cboe that seeks twice the daily percentage return of Xanadu Quantum Technologies, a Toronto-based photonic quantum-computing developer. In Monday's session, with U.S. markets open and trading through the afternoon, the ETF changed hands at $0.2212, down $0.0719 or 24.53% from the prior session's close of $0.2931. The direction is unambiguously lower. No fund-specific filing or issuer announcement drove the move; the decline tracks a sector-wide retreat in quantum equities and a 10.92% drop in the underlying shares, amplified by the fund's 2x daily leverage and its own evaporation of share price.
The dominant force is group weakness. Quantum pure-plays sold off together as investors continued rotating away from pre-revenue, high-valuation technology names, with the Nasdaq-100 down about 2% and the quantum complex lower across the board. IonQ, D-Wave and Rigetti all fell sharply despite reporting large year-over-year revenue growth this quarter, which tells traders that scale is not currently sheltering the group. Because Xanadu carries one of the thinnest revenue bases in the sector and the deepest drawdown, it absorbs some of the heaviest selling pressure when sentiment turns.
Xanadu's Nov. 11 third-quarter report remains the fundamental anchor. Revenue of $1.31 million rose 32% year over year but landed well short of consensus near $2.22 million, and slipped sequentially from $1.5 million. Research and development spending climbed 67% to $25.6 million and general and administrative costs jumped 129% to $9.2 million, pushing the net loss to $32.2 million from $20.3 million a year earlier. With $286.5 million of cash and $232.8 million still available under a synthetic at-the-market equity facility, the market is discounting future share issuance faster than it is discounting the photonic roadmap — including the 7-millidecibel optical switch milestone and manufacturing partnerships with ASML, GlobalFoundries and Bluefors.
Royal Bank of Canada lowered its price target on Xanadu to $13 from $16 on Friday, maintaining an outperform rating — a signal that even supportive analysts are trimming expectations. Morgan Stanley's equal-weight rating with a $3.75 target sits far closer to the current share price, and a newly published sell-side view arguing that cash needs of roughly $35 million a quarter imply dilution before the 2029 machine target has reinforced the bear case. None of this is new on Monday, but it explains why rallies in the underlying have failed.
Turnover in Xanadu has been running below its 30-day average, so today's slide reflects persistent selling pressure rather than a single volume-driven flush. The fund itself is tiny, with total assets near $3.3 million, leaving an order book thin enough that modest flows move the quoted price. Xanadu broke below Friday's 52-week low of $2.22 and trades far under its 50-day average near $2.74 and its 200-day average near $11, a structure consistent with a broken downtrend rather than a base. The move diverged from broader technology benchmarks only in magnitude: mega-cap tech slipped moderately, while speculative quantum names fell multiples of that.
The scale runs from 0, meaning no meaningful news and a normal move, to 100, meaning transformative news and an extreme, rare price move. This event scores 26 out of 100. The verified news is real but not fresh: a material quarterly revenue miss, widening losses and a $232.8 million dilution facility together with a round of analyst target cuts. That is moderate rather than transformative, and none of it was published today. The price move was roughly 2.3 times the fund's typical absolute daily change of about 10.5% over the past 60 sessions, and only two of those 60 sessions produced an equal or larger decline. Moderate news plus a moderately unusual move combines into a low-to-mid score.
Attention stays on Xanadu's December 31 fiscal year-end and the fourth-quarter report expected in the first quarter of 2027, when investors will look for revenue durability beyond DARPA and partnership contracts and for confirmation that the $140 million Canadian loan is being drawn on schedule. Watch the cash balance for signs the equity line is being tapped, and watch peer results from IonQ, D-Wave and Rigetti for sector direction. For XNDX specifically, daily reset mechanics mean volatility decay accelerates in choppy markets, so the fund can lose ground even if the underlying is flat. Risks include continued sector de-rating, further target cuts and financing needs.
Tickeron maintains hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions earn a place in the curated Trending AI Robots section. Bots differ by strategy, timeframe, performance metrics and traded symbols, so the lineup rotates as conditions change. For volatile names like this one, reviewing which automated strategies are actually working right now is a practical way to add discipline to the process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for XNDX moved into overbought territory on November 13, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +41.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where XNDX advanced for three days, in 9 of 12 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XNDX as a result. In 6 of 6 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XNDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for XNDX entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.